GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment

2022/01/04 by Maria Buur Nordskov Gabe, M Gabe, Kirsa Skov‐Jeppesen +21 · 2 citations
Biochemistry, Genetics and Molecular Biology · Medicine · Neuroscience · #Diabetes Treatment and Management #Metabolism, Diabetes, and Cancer #Neuropeptides and Animal Physiology

paper · doi:10.1016/j.phrs.2022.106058

openalex publication_date 2022/01/04 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Citations

• Pharmacokinetics and Pharmacokinetic–Pharmacodynamic Correlations of Therapeutic Peptides
• Bisphosphonates: Mechanism of Action and Role in Clinical Practice

Cited by

• GLP ‐2 and GIP acutely increase superior mesenteric artery blood flow in male rats, and the effect is independent of nitric oxide and vasoactive intestinal peptide
• Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease